Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Protagonist Therapeutics (PTGX)

Protagonist Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PTGX
DateTimeSourceHeadlineSymbolCompany
07/05/202421:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTGXProtagonist Therapeutics Inc
07/05/202421:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
16/04/202414:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202401:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202401:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
02/03/202401:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
01/03/202421:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
29/02/202422:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
29/02/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
27/02/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
14/02/202412:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTGXProtagonist Therapeutics Inc
14/02/202412:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PTGXProtagonist Therapeutics Inc
31/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
19/01/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
19/01/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
16/01/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
12/01/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
09/01/202422:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
08/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
05/01/202401:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTGXProtagonist Therapeutics Inc
18/12/202321:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PTGXProtagonist Therapeutics Inc
02/11/202321:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTGXProtagonist Therapeutics Inc
02/11/202320:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
30/10/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTGXProtagonist Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PTGX

Your Recent History

Delayed Upgrade Clock